Upcoming WPA Educational Activities

Sections & Education / Education / Activity Schedule

Upcoming WPA Educational Activities

Like so many organisations around the globe, the COVID-19 pandemic has forced companies to move online. WPA has embraced this movement and are now working hard seeking collaborations to create and run educational online courses. The below is a list of upcoming courses.

Please regularly check back here to make sure you do not miss out on any new courses added.

Image by Ahmed Raza Kz

Schizophrenia Clinical Trials - what they tell us?

Friday 27th May 2022, Time: 14:00 (CEST)

Clinical trials are the cornerstone of current evidence-based medicine. Designs range from effectiveness trials with maximized internal validity but limited external generalizability, to effectiveness and large simple trials that maximize external validity but have reduced precision. Data analytics have equally evolved and become very sophisticated, and it has become increasingly important to choose the most appropriate statistical analysis plan for a given trial design, research question and attempt at minimising type I and/or type II error. Trial design, conduct and interpretation are critical components that need to be focused on. Both failed and successful trials provide an opportunity for learning.

Course Directors

Prof Afzal Javed President World Psychiatric Association

Prof Peter Morozov Secretary General World Psychiatric Association

Image by Ahmed Raza Kz

Individualised Management of Schizophrenia

Friday 7th July 2022, Time: 17:00 (CEST)

Negative symptoms are present in more than 50% of people with schizophrenia, have a significant impact on real-life functioning, and pose a substantial burden on the affected people and their families. This webinar will focus on: 1) psychopathological constructs currently regarded as relevant to the negative symptom dimension; 2) the distinction between primary and secondary negative symptoms and its relevance to clinical practice; 3) the main differences among current definitions of deficit schizophrenia, persistent negative symptoms, prominent negative symptoms and predominant negative symptoms; 4) recommendations for recognizing and assessing negative symptom domains with the appropriate tools.

Course Directors

Prof Afzal Javed, President WPA

Prof Peter Morozov, Secretary General WPA

Prof. Roger Ng, Secretary Education, WPA

Image by Ahmed Raza Kz

Schizophrenia - Before Assuming Non-Response to Antipsychotic Treatment

Friday 14th July 2022, Time: 14:00 (CEST)

Schizophrenia is a mental disorder characterized by continuous or relapsing episodes of psychosis. Symptoms typically come on gradually, begin in young adulthood, and in many cases never resolve. About half of those diagnosed with schizophrenia will have a significant improvement over the long term with no further relapses, and a small proportion of these will recover completely. The other half will have a lifelong impairment. In some cases, people may be repeatedly admitted to hospitals. Social problems such as long-term unemployment, poverty, homelessness, exploitation, and victimization are commonly correlated with schizophrenia. The mainstay of treatment is antipsychotic medication, along with counselling and social rehabilitation.

Course Directors

Prof Afzal Javed, President WPA

Prof Peter Morozov, Secretary General WPA

Prof. Roger Ng, Secretary Education, WPA